An individual with cirrhosis is considered to be at higher risk of HCC, and increased levels of alpha fetoprotein (AFP) often serves as clinical biomarker for HCC diagnosis, yet its sensitivity is not very promising (4). Here, AFP is linked to hepatocellular carcinoma.